Viking Therapeutics' stock tumbles after results of oral weight-loss drug trial. It has company.Market Watch • 08/19/25
Viking Therapeutics Crashes 41% On Mixed Results For Its Weight-Loss PillInvestors Business Daily • 08/19/25
Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with ObesityPRNewsWire • 08/19/25
If You'd Invested $1,000 in Viking Therapeutics 3 Years Ago, Here's How Much You'd Have TodayThe Motley Fool • 08/12/25
Viking Therapeutics (VKTX) Is Considered a Good Investment by Brokers: Is That True?Zacks Investment Research • 08/04/25
2 Biotech Stocks That Could Soar 29% and 165% According to Wall Street's Top AnalystsThe Motley Fool • 08/03/25
Viking Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate UpdatePRNewsWire • 07/23/25
Viking Therapeutics Gears Up for Q2 Earnings: Here's What to ExpectZacks Investment Research • 07/21/25
These 2 Stocks Could More Than Double Your Money, According to Wall Street. Is It Time to Buy?The Motley Fool • 07/20/25
After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead.The Motley Fool • 07/19/25